… screened 48 FDA-approved drugs based on our SARS-CoV screening, and our screening
campaign revealed 24 potential antiviral drug candidates against SARS-CoV-2. Our findings …

… severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) … these compounds as
potential SARS-CoV-2 drug candidates. … compounds as potential SARS-CoV-2 drug candidates. …

… There exists a number of candidate drugs that may inhibit infection with and replication of
SARS-CoV-2. Such drugs comprise inhibitors of TMPRSS2 serine protease and inhibitors of …

… that this compound is a promising drug candidate. … The x-ray crystal structures of SARS-CoV-2
M pro in complex with … suggests that these compounds are promising drug candidates. …

… SARS-CoV-2 being a new virus with unusually high mortality, there has been a need to get
medicines in an emergency, and the drug … attempt to discover the drugs interacting with RAS …

… have virtually screened FDA approved drugs, drug candidates and natural compounds.
The … The known drugs which were identified as potential inhibitors of NSP16 from SARS-CoV-2 …

… We aim to identify repurposable drug candidates (green drugs) targeting these key host
modulators to interfere with virus replication and disease progression following infection. …

… targeting SARS-CoV-2 M pro . However, the mechanism of action of SARS-CoV-2 M pro
at … key interactions between SARS-CoV-2 M pro and three drug candidates by performing …

… of anti-SARS-CoV-2 nanobody drug candidates, Nanosota-1. … SARS-CoV-2 RBD, the
Nanosota-1 series bound potently to the SARS-CoV-2 RBD and were effective at inhibiting SARS-…

… library on the basis of drug repositioning. The drug candidates presented in this study
could be further examined for their anti-SARS-CoV-2 activities, together with those of earlier …